Multiple Myeloma Patients in UK Gain Access to Ninlaro through Cancer Drugs Fund
Multiple myeloma patients in the United…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreMultiple myeloma patients in the United…
In an era of new therapies with unprecedented efficacy, high-dose…
Pretreating multiple myeloma patients with Ethyol (amifostine) prior to…
The Multiple Myeloma Research Foundation and Karyopharm Therapeutics are hoping…
Animal studies have shown that a new treatment strategy…
Multiple myeloma patients who received several prior lines…